N/A
Completed N=46
Drug Utilization Study for Pirinase Hayfever Relief
Rhinitis, Allergic, Seasonal
Source: ClinicalTrials.gov NCT02856282 ↗
Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcomePrimary: Number of Participants Who Used the Test Product at Correct Age (18 Years or Older) — 45 Participants
Summary
The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Used the Test Product at Correct Age (18 Years or Older) |
45 | — |
| PRIMARY Number of Participants Who Did Not Exceed the Correct Frequency of Use (2 Sprays Per Nostril Per Day) |
32 | — |
| PRIMARY Number of Participants With Improved Symptoms Who Reduced the Doses to 1 Spray Per Nostril Per Day |
30 | — |
| PRIMARY Number of Pregnant/ Breastfeeding Participants Who Consulted Physician Before Product Use |
— | — |
| PRIMARY Number of Participants Who Consulted Physician if Symptoms Were Not Improved After Using Test Product for 7 Days |
— | — |
| SECONDARY Number of Participants Who Used the Test Product and Were Not Taking a Medication for Human Immunodeficiency Virus (HIV) |
44 | — |
| SECONDARY Number of Participants Who Consulted Physician When Test Product Was Used for 1 Month or More Continuously |
3 | — |
Eligibility Criteria
Inclusion Criteria
- Participants will be required to review, and electronically sign a Participation Agreement prior to completing the online survey.
- Participants of any age may participate.
- Participants who have purchased and used Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for at least 7 days and are willing to participate in the online survey.
- Participants of either gender may participate
Exclusion Criteria
- Anyone who is directly involved with medicines such as doctors, nurses, and pharmacists.
- Participants who decline participation in the online survey
Data sourced from ClinicalTrials.gov (NCT02856282). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.